ATLANTA, May 18, 2018 /PRNewswire/ -- Elekta (EKTA-B.ST) today announced that Allegheny Health Network (AHN), a Highmark Health Company, has purchased Elekta products and services as the complete solution for its radiation oncology needs at Saint Vincent Hospital, Forbes Hospital, AHN Cancer Institute-Butler and AHN Cancer Institute - Beaver. AHN has ordered four Versa HD™ linear accelerators, Flexitron® afterloaders for brachytherapy treatments as well as Elekta's MOSAIQ® oncology information system and Monaco® treatment planning system.

This acquisition is part of an exclusive agreement signed in 2014 to equip AHN medical centers with sophisticated cancer treatment equipment and information management systems from Elekta.

"AHN and Highmark Health have made a long-term commitment to improve access and expand services that help prevent, diagnose and treat cancer and support cancer patients throughout the entire care continuum," said David Parda, M.D., Chair, AHN Cancer Institute. "As part of that commitment, we want to not only ensure that our network hospitals have the most advanced oncology products and services available today, but also establish relationships that allow us to remain at the forefront of oncology as new innovations are brought to market. Elekta is not only the leading innovator of today's radiation oncology solutions, it is also the partner of choice for providing a complete package of patient-centric radiation therapy care options in an evolving technology and healthcare economic landscape."
The Cancer Institute's radiation oncology program has a formal affiliation with the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, one of the nation's 41 comprehensive cancer centers designated by the National Cancer Institute, for research, medical education and clinical services.

Peter Gaccione, Executive Vice President, Region North and Latin America, Elekta, said: "Elekta is very honored to provide AHN with innovative technologies that deliver more efficient, personalized cancer care and improved patient outcomes. AHN is committed to providing patients throughout its region with the best cancer care possible to tailor treatments that meet the specific needs of individual patients. This approach is entirely aligned with Elekta's vision for improving cancer therapy and we are proud to have the opportunity to partner with AHN to achieve our mutual goals."

Since signing the 2014 agreement, AHN has invested in the following Elekta treatment delivery and software solutions:

Health IT Homepage